Related references
Note: Only part of the references are listed.MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells
Paul Zarogoulidis et al.
CELLULAR SIGNALLING (2015)
MiR-218 Mediates tumorigenesis and metastasis: Perspectives and implications
Ying-fei Lu et al.
EXPERIMENTAL CELL RESEARCH (2015)
ADAM9 Promotes Lung Cancer Metastases to Brain by a Plasminogen Activator-Based Pathway
Chen-Yuan Lin et al.
CANCER RESEARCH (2014)
ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
Yuh-Pyng Sher et al.
PLOS ONE (2014)
MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation, and Cancer Stem-like Cell Self-Renewal by Targeting the Polycomb Group Gene Bmi1
Yanyang Tu et al.
CANCER RESEARCH (2013)
Distinct microRNA Expression Profiles in Prostate Cancer Stem/Progenitor Cells and Tumor-Suppressive Functions of let-7
Can Liu et al.
CANCER RESEARCH (2012)
miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets
Tzu-Pin Lu et al.
PLOS ONE (2012)
miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway
Nehad M. Alajez et al.
CANCER RESEARCH (2011)
The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer
Atsushi Uesugi et al.
CANCER RESEARCH (2011)
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma
Hui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
Fazli Wahid et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Paxillin Predicts Survival and Relapse in Non-Small Cell Lung Cancer by MicroRNA-218 Targeting
De-Wei Wu et al.
CANCER RESEARCH (2010)
被撤回的出版物: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (Retracted article. See vol. 161, pg. 417, 2015)
Scott Valastyan et al.
CELL (2009)
The Expression of Three Genes in Primary Non-Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain
Helena Grinberg-Rashi et al.
CLINICAL CANCER RESEARCH (2009)
The Cell Surface Glycoprotein CDCP1 in Cancer-Insights, Opportunities, and Challenges
Andreas Wortmann et al.
IUBMB LIFE (2009)
ADAM9 Is Involved in Pathological Retinal Neovascularization
Victor Guaiquil et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival
Y-P Sher et al.
ONCOGENE (2009)
Medical management of brain metastases from lung cancer
Ryuya Yamanaka
ONCOLOGY REPORTS (2009)
CUB domain-containing protein 1 is a novel regulator of Anoikis resistance in lung adenocarcinomavt
Takamasa Uekita et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Update in the treatment of brain Metastases from lung cancer
Amanda L. Schwer et al.
CLINICAL LUNG CANCER (2006)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis
Y Shintani et al.
CANCER RESEARCH (2004)
Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen
JD Hooper et al.
ONCOGENE (2003)
Share Paper
